Alter Ego Pharmaceuticals
Tacrolimus (0.1% w/w)
Tacmute 0.1% Cream is used to treat eczema (atopic dermatitis) by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin, relieving itching and improving rashes.
Cream
Tacmute 0.1% Cream is used for external use to treat eczema (atopic dermatitis). It should be used 2-4 times a day on the affected area or as suggested by the doctor. It should be applied slowly and evenly to the skin until it is rubbed in. You should not use it too often and you should not cover the treated area with a bandage or plaster. You must inform your doctor if there’s no improvement even after two weeks of treatment or if the skin gets worse.
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the cream. Wash your hands after applying unless hands are the affected area.
Erythema Headache Inflammation of hair follicle Application site reaction like burning, irritation, itching, and redness
Tacmute 0.1% Cream is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Tacmute 0.1% Cream may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Rotavirus vaccine (live attenuated oral) Live Attenuated Varicella-Zoster Virus Measles Vaccine (Live) Rubella vaccine (Live)
Tacmute 0.1% Cream is an immunosuppressant. It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin, relieving itching and improving rashes in atopic dermatitis.
Apply thinly to affected areas of skin only Clean the affected area and dry well before applying Tacmute 0.1% Cream Avoid contact with water after application Inform your doctor if there's no improvement even after two weeks of treatment or if the skin gets worse Don't cover the area being treated with airtight dressings such as bandages unless directed by a doctor Stop using Tacmute 0.1% Cream and consult your doctor if your eczema becomes infected Continuous long-term use of the ointment should be avoided. Use as prescribed by your doctor
Tacmute 0.1% Cream is a medicine that modulates the immune system. It works on the immune system and primarily decreases its activity. It is used to treat moderate to severe eczema (atopic dermatitis) in adults who do not respond to steroids or develop side effects from using them.
Tacmute 0.1% Cream, when applied topically to the skin, may cause skin irritation, burning sensation, and itching at the site of application. These are usually mild to moderate in severity and normally resolve within one week of starting treatment. Redness is also a common manifestation along with sensations of warmth, pain, altered sensation, and rash at the site of application. Using Tacmute 0.1% Cream increases the patients' increased risk of getting inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacmute 0.1% Cream has been found to be a safe and effective short-term treatment for atopic dermatitis when compared to other immune-suppressing medications. The absorption of this medication to the blood and body is minimal, resulting in reduced side effects as compared to oral administration.
No, Tacmute 0.1% Cream does not have abuse potential and is not a controlled substance. Controlled substances have potential for abuse so they require authorization by authorities and a doctor's permission for use.
Long-term use of Tacmute 0.1% Cream has been associated with increased risk of lymph node tumors called lymphoma. Some studies have found that a few patients who used Tacmute 0.1% Cream ointment or another similar medication developed skin cancer or lymphoma. Consult your doctor if you need to use Tacmute 0.1% Cream for more than six weeks, or if your eczema symptoms haven't improved or are worsening during treatment.
No, Tacmute 0.1% Cream is not a steroid. It is a medicine that modulates the immune system activity. It is used in the treatment of eczema, most commonly in atopic dermatitis. A notable advantage of Tacmute 0.1% Cream is its lack of skin thinning (atrophy) or other steroid-related side effects.